Insider · CIK 0001998771
Theresa Greco
Files at OPRX (OptimizeRx Corp). First filing -, latest -.
In brief
Theresa Greco files SEC Form 4 as officer at OPRX (OptimizeRx Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Theresa Greco has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -914 | $5.21 | $4,762 | 71,954 | May 18, 2026 |
| May 15, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -879 | $5.21 | $4,580 | 71,075 | May 18, 2026 |
| Dec 23, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,420 | $12.74 | $18k | 72,868 | Dec 23, 2025 |
| Nov 1, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,693 | $20.49 | $35k | 74,288 | Nov 3, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +15,625 | $0.00 | $0 | 75,981 | Aug 25, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +35,156 | $0.00 | $0 | 35,156 | Aug 25, 2025 |
| May 15, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +2,441 | $0.00 | $0 | 53,314 | May 19, 2025 |
| May 15, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +7,042 | $0.00 | $0 | 60,356 | May 19, 2025 |
| May 15, 2025 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +12,133 | $0.00 | $0 | 12,133 | May 19, 2025 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +15,528 | $0.00 | $0 | 50,873 | Dec 27, 2024 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +29,153 | $0.00 | $0 | 29,153 | Dec 27, 2024 |
| Nov 1, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,693 | $5.15 | $8,719 | 35,345 | Nov 5, 2024 |
| Nov 1, 2023 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +18,519 | $0.00 | $0 | 37,038 | Nov 3, 2023 |
| Nov 1, 2023 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +35,758 | $0.00 | $0 | 35,758 | Nov 3, 2023 |
Questions about Theresa Greco
Answered from the filings on this page, as of the latest one.
Is Theresa Greco buying or selling?
Theresa Greco has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Theresa Greco's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Theresa Greco has 0.
Where does Theresa Greco file Form 4?
Theresa Greco has filed Form 4 at OPRX (OptimizeRx Corp) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.